Nasonex - olelo ao no ka hoʻohana.

E hoomakaukau ai "Nazoneks" Ua lako like me ka slurry keʻokeʻo pahaʻaneʻane nō keʻokeʻo me kaʻehu.

nā mea hoʻohui:

ʻeleu ka waiwai:

• Mometasone Furoate - 50 micrograms (1 mahele lāʻau)

Excipients:

• polysorbate
• glycerol
• kelulose lakou hoopuehu
• Dihydrate paʻakai citrate
• Citricʻakika monohydrate
• Benzakoniya koloriside
• phenyl'eto waiʻona
• maloko o ka wai

Pharmacological 'ole

Medicine "Nasonex" o ka kūloko SCS hope i loaʻa Anati-allergic a me Anati-hoʻoʻino hana. Local lāʻau hana hiki i wale nō i loko o nā māhele i e ole pili i ka systemic loa.

Ke k inhibits ka? Iecaianoaaiiie o hoʻoʻino uao. Ka makaukau maoli o ka hoʻololi kemikala lipomodulin, a mea he inhibitor o phospholipase A, ma ia hoemi ea puka a me ka arachidonicʻakika me pono me inhibition o ka hoʻololi kemikala o kona metabolites - a cyclic endoperoxides prostaglandins.

Eia kekahi, Nazoneks e emi i ka hoʻololi kemikala o chemotactic waiwai, ma laila inhibiting i ka hoʻomaka 'ana o koke allergic naoh.

Nō hoʻi, kiʻekiʻe Anati-hoʻoʻino hana i pili i ka nasal mucous membranes i ike i noiʻi.

Pharmacokinetics Nasonex

Aʻo mai nei i ka bioavailability o ka lāʻau ma ka nasal noi - emi o 0,1%. Eia hou kekahi, mometasone furoate loa poorly ho'ākāka 'ia ma ke koko. Ku paha māhele o ka lāʻau i loko o ka gastrointestinal'āpana, akā, ma keia hihia, ma ka hooholo mua o ka lāʻau ma ke akepaʻa,ʻo ia 'Imi biotransformed.

nāʻikepili Nazoneks

Na Ke Kumu e hoʻokomo i kekahi i ka papa inoa o nāʻikepili no ka pono o ko mākou huahana.

• Lapaʻau o allergic rhinitis i loko o nā mea a pau makahiki pūʻulu (koe wale no na keiki ma lalo o 2 makahiki)
• Iapaau ana o ka maʻi sinusitis i loko o nā mea a pau makahiki pūʻulu (no ka hui pu ana, Inc)
• Kāohiʻana o allergic rhinitis (pono e lawe no 2-4 pule)

ʻaoʻao 'ole o Nasonex

Alakaʻi e haʻi ana i ka likeʻole ʻaoʻao waiwai, ke kaumaha ma muli o ka nenoai a me nā loko.

ʻaoʻao 'ole Nasonex like me ka iniiaiie kumu o ka hana maikaʻiʻole o ka rhinitis:

• Epistaxis (pelapela, a precipitates i hookohu aku i)
• pharyngitis
• Loa o ka nasal mucosa
• A ahi ka waiʻona ma loko o ka ihu

Nosebleeds IeAUPIIe, IAa IO ka noonoo ana ma luna o kona iho i loko o kekahi mau lā, a ua ole loa lawa. I na keiki, na symptoms i pākuʻi i ka luna o ka headache kekahi, kihe.

ʻaoʻao 'ole o Nasonex me he kokua ma ka iapaau ana o ka sinusitis:

• pharyngitis
• headache
• ae hookaawale
• A ahi ka waiʻona ma loko o ka ihu

Nosebleeds he kakaikahi, a he poe wale no he mau lā,

Loa pohihihi, akā nō e hiki 'ole o ka nasal septum perforation, i kekahi pohihihi, akā, i ka manawa kūpono o ka mahuahua intraocular puʻe.

E hoomanawanui i ka poe i malamaia lakou nei, me corticosteroids i he ho'ēmi i kā ia'ku, aka, i i ka māhuahua pilikia o ka maʻiʻaʻai i loko o ka wā e hiki mai.

Hawaiʻi ma ka hopena o ka lāʻau ma ka hāpai keiki ua i lawe mai, akā, e like me ka mea lehulehu o ka lāʻau i loko o ke koko ma hope o hooponopono mea he uuku hiki ke ea i ka fetus e e hoolilo uuku loa kuleana, a, nolaila, haʻahaʻa kaʻawahia. Naʻe, i ka hookohu o ka lāʻau i ka hapai, breastfeeding, a me nā wāhine o ka hanau keiki makahiki, e ke i wale ma hope o na hoahanau a pau o ke ola ka pilikia a hiki i ka hoʻomanawanui, a me ka unborn keiki.

Contraindications

• Up i 2 makahiki
• Postoperative eha paha trauma o ka ihu
• tuberculosis
• Untreated fungal maʻiʻaʻai
• Untreated mea koʻohune maʻiʻaʻai
• Systemic mea hoʻomaʻi maʻiʻaʻai
• Pā lonoaʻili i ka

An overdose o Nasonex

Manual 'Aʻole i loaʻa kekahi' ike i overdose me keia k, mahope mai o ka lāʻau i ka kŘpa a haʻahaʻa bioavailability, i ka iapaau ana o ka overdose, e like me ka rula, 'aʻole e koi i ka hookamaia o ka ho'ākāka' ana. Ina o ka overdose he symptomatic lapaʻau E e ia.

lāʻau hana kūleʻa

Haʻawina i ole, ua hana.